17.05.2024 – 02:01
Full-Life Technologies Limited
Gembloux, Belgium (ots/PRNewswire)
Full-Life Technologies (Full-Life), a totally built-in international radiation oncology firm, at the moment introduced the appointment of Mark S. de Jong, PhD, to the newly created place of Chief Technical Officer (CTO). Dr. de Jong involves Full-Life with 43 years of management expertise and experience in accelerator physics and isotope manufacturing, together with business radioisotope manufacturing utilizing linear accelerators. He got here from Canadian Isotope Innovations Corp. to Full-Life, the place he served as head of know-how.
At Canadian Isotope Innovations Corp. He led the event and operation of the MIP (Medical Isotope Production) facility with a 35-megavolt linear electron accelerator for the manufacturing of medical isotopes. His duties included main the event of latest radioisotopes for medical functions utilizing electron accelerators and main the event of electron accelerators and focusing on know-how for the manufacturing of medical isotopes.
Previously, Dr. de Jong held the place of Head of the Medical Isotopes Division at Canadian Light Source Inc. (CLS). During his tenure, he led the event, operation and commercialization of the MIP facility with a 35 MeV linear electron accelerator for the manufacturing of molybdenum-99 (99Mo) for medical functions. Under his management, quite a few groundbreaking initiatives had been efficiently carried out, together with the design and commissioning of a 2.9 GeV electron synchrotron for CLS and the event of a photo-neutron course of for the manufacturing of 99Mo. He has additionally developed key software program instruments for nuclear security programs for energy vegetation, making certain their protected operation.
The excellent profession of Dr. de Jong is characterised by his exemplary management function and his lively participation in quite a few famend nationwide and worldwide committees. In explicit, he was scientific director of the International Atomic Energy Agency (IAEA) coordinated analysis challenge on new strategies for producing technetium-99m (Tc-99m), an necessary medical isotope. He has additionally held management positions on worldwide advisory committees, together with on the Taiwan Photon Source and the Shanghai Synchrotron Radiation Facility.
Dr. de Jong’s dedication to scientific progress can be evident in his contributions to worldwide organizations such because the International Electrotechnical Commission and the OECD Nuclear Energy Agency. Dr. de Jong’s contributions to the sphere have been acknowledged with prestigious awards, together with the AECL Distinguished Merit Award and the University of Manitoba Honored Alumni Award. He holds a PhD in physics from the University of Manitoba.
“Dr. de Jong has a superb background in particle accelerator know-how, notably within the pharmaceutical sector. His function can be of nice significance in our efforts to implement a state-of-the-art particle accelerator for radioisotope manufacturing,” stated Philippe van Put, Managing Manager of Full-Life Technology Europe. “With his in depth expertise in medical isotope manufacturing and his confirmed observe file In the event and administration of electron accelerator services, Dr. de Jong is effectively outfitted to take our initiatives to the following stage of improvement. His management abilities, technical abilities and long-term strategic administration of accelerator services have earned him worldwide recognition and a spot on prestigious committees and initiatives We look ahead to the brand new views and modern approaches that Dr. de Jong will carry to our crew.”
Information about Full-Life Technologies
Full-Life Technologies Limited (“Full-Life”) is a totally built-in, international radiotherapeutics firm with workplaces in Belgium, Germany and China. Our aim is to grasp your entire worth chain of radiopharmaceutical analysis and improvement, manufacturing and commercialization to ship medical advantages to sufferers. The firm plans to beat the core issues of at the moment’s radiopharmaceuticals by modern analysis aimed toward tomorrow’s therapies. We are a crew of dynamic entrepreneurs and scientists with a confirmed observe file within the life sciences and in radioisotope analysis and medical improvement.
View unique content material: https://www.prnewswire.com/de/pressemitteilungen/full-life-technologies-gibt-die-ernennung-von-mark-s-de-jong-phd-zum-technischen-leiter-bekannt-302146226.html
Press contact:
Full-Life,
[email protected],
www.full-life.com
Original content material from: Full-Life Technologies Limited, transmitted by information aktuell